8-Aminoclonazolam is a metabolite of clonazolam; Clonazolam is used as a central nervous system depressant.
Trend reports developed by NPS Discovery previously indicated a decline in clonazolam positivity in Q3 2020. However, recent developments show that the positivity of clonazolam is currently increasing based on new data collected after testing for its metabolite.